EORTC-24872-HNCG

Randomized phase III trial of methotrexate vs 10-EdAm, a new methotrexate analogue,in patients with advanced squamous cell carcinoma of the head and neck
Trial StatusAll trial activities ended
DatesDate of activation: 15-Mar-88
Closed on : 19-Feb-92
Data management at EORTCFull
Phase2
Randomized trialYes
TypeAdvanced
Targeted Sample size40
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
@
Back to Protocol section